STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Autor: | Shan Lin, Amy Saur Conway, Biniam Adane, Amanda Balboni Iniguez, Richard A. Young, Neekesh V. Dharia, Elizabeth Hwang, Francisca Vazquez, Filemon S. Dela Cruz, Diana Lu, Kimberly Stegmaier, Gabriela Alexe, John M. Krill-Burger, Caleb A. Lareau, Bo Kyung A. Seong, Jason N. Berman, Andrew L. Kung, Benjamin Tanenbaum, Monica Schenone, Martin J. Aryee, Denes Hnisz, Amanda L. Robichaud, Melissa Richardson, Linda Ross, Brian D. Crompton, Abraham S. Weintraub, Steven A. Carr, Sarah Wang |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Cancer Research Oncogene Proteins Fusion Chromosomal Proteins Non-Histone Bone Neoplasms Cell Cycle Proteins Sarcoma Ewing Article 03 medical and health sciences 0302 clinical medicine Cell Movement Mice Inbred NOD Cell Line Tumor Animals Humans Promoter Regions Genetic Enhancer Transcription factor Zebrafish Homeodomain Proteins Regulation of gene expression biology Cohesin Proto-Oncogene Protein c-fli-1 Polycomb Repressive Complex 2 Nuclear Proteins Xenograft Model Antitumor Assays Chromatin Cell biology Gene Expression Regulation Neoplastic Enhancer Elements Genetic 030104 developmental biology Oncology 030220 oncology & carcinogenesis FLI1 POU Domain Factors biology.protein Female RNA-Binding Protein EWS PRC2 Reprogramming |
Zdroj: | Cancer Cell |
ISSN: | 1535-6108 |
Popis: | The core cohesin subunit STAG2 is recurrently mutated in Ewing sarcoma but its biological role is less clear. Herein, we demonstrate that cohesin complexes containing STAG2 occupy enhancer and polycomb repressive complex (PRC2) marked regulatory regions. Genetic suppression of STAG2 leads to a compensatory increase in cohesin-STAG1 complexes, but not in enhancer rich regions, and results in reprogramming of cis-chromatin interactions. Strikingly, in STAG2 knockout cells, the oncogenic genetic program driven by the fusion transcription factor EWS/FLI1 was highly perturbed, in part due to altered enhancer-promoter contacts. Moreover, loss of STAG2 also disrupted PRC2-mediated regulation of gene expression. Combined, these transcriptional changes converged to modulate EWS/FLI1, migratory and neurodevelopmental programs. Finally, consistent with clinical observations, functional studies revealed that loss of STAG2 enhances the metastatic potential of Ewing sarcoma xenografts. Our findings demonstrate that STAG2 mutations can alter chromatin architecture and transcriptional programs to promote an aggressive cancer phenotype. |
Databáze: | OpenAIRE |
Externí odkaz: |